Stocks / NYSE / C.R. Bard, Inc.

C.R. Bard, Inc.

Our Opinion

C.R. Bard, Inc. is on the Cruelty Free Investing use of animals list because they conduct Pre-clinical studies of their drugs, devices on animals to assess a product’s safety profile.

Supporting Evidence:

Bard Davol Inc. has conducted an animal study for C.R. Bard. The following document cites that, “The study was conducted for and sponsored by C.R. Bard. This study represents a preclinical evaluation of the SorbaFix™ Device following in vivo implantation in an animal model”. (Reference section of the document)

Company Description

C.R. Bard, Inc. designs, develops, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices. It sells a broad range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. The company’s products include vascular, urology, oncology and surgical specialty products. C. R. Bard was founded by Charles Russell Bard in 1907 and is headquartered in Murray Hill, NJ.[Source: MarketWatch]

Company Website: